Alexander Von Humboldt Foundation

Vanderbilt researchers have developed an active machine learning approach to predict the effects of tumor variants of unknown significance, or VUS, on sensitivity to chemotherapy. Characterizing VUS can maximize clinical care and precision medicine for each patient. Read More

Ege T. Kavalali, PhD, professor and acting chair of the Department of Pharmacology in the Vanderbilt University School of Medicine, has been elected a recipient of a prestigious Humboldt Research Award by the Alexander von Humboldt Foundation of Germany. Read More

Associate Professor of Chemistry Jens Meiler has received a Friedrich Wilhelm Bessel Research Award from the Alexander von Humboldt Foundation in Bonn, Germany. Read More

A method for taking ultrafast "sonograms" of materials undergoing phase transitions sheds new light on the dynamics of this important phenomenon in the world’s fastest phase-change material. Read More